These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 9162925)

  • 1. [Effectiveness of complex treatment in combination with short-wave therapy and protease inhibitors in first detected patients with pulmonary tuberculosis].
    Lomachenkov VD; Kuprikova IM; Golubeva VS; Pochtennyi IT; Nikolaeva GM
    Probl Tuberk; 1997; (1):42-4. PubMed ID: 9162925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [New cases of pulmonary tuberculosis treatment within DOTS strategy].
    Zhangireev AA; Ismailov ShSh; Berikova EM
    Probl Tuberk; 2000; (3):23-5. PubMed ID: 10900979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Park SK; Kim JH; Kang H; Cho JS; Smego RA
    Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Resistance of Mycobacterium tuberculosis strains isolated from patients to antituberculosis drugs].
    Sybirna RI; Iavors'ka GV
    Mikrobiol Z; 2001; 63(4):91-5. PubMed ID: 11692684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Drug resistance of Mycobacteria tuberculosis in patients with new-onset pulmonary tuberculosis].
    Khudushina TA; Voloshina EP; Adamovich NV; Maslakova MG; Terekhova ND
    Probl Tuberk Bolezn Legk; 2005; (12):37-9. PubMed ID: 16496762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Spread of drug-resistant strains of mycobacterium tuberculosis among patients with isolated bacteria].
    Zhukova MP
    Probl Tuberk; 1998; (1):14-6. PubMed ID: 9553424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Long-term results of treatment of drug-resistant pulmonary tuberculosis in adolescents].
    Firsova VA; Poluĕktova FG; Ryzhova AP
    Probl Tuberk Bolezn Legk; 2005; (7):25-8. PubMed ID: 16130423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of molecular techniques to distinguish between treatment failure and exogenous reinfection with Mycobacterium tuberculosis.
    Krüüner A; Pehme L; Ghebremichael S; Koivula T; Hoffner SE; Mikelsaar M
    Clin Infect Dis; 2002 Jul; 35(2):146-55. PubMed ID: 12087520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of isoniazid-resistant tuberculosis with isoniazid, rifampin, ethambutol, and pyrazinamide for 6 months.
    Nolan CM; Goldberg SV
    Int J Tuberc Lung Dis; 2002 Nov; 6(11):952-8. PubMed ID: 12475140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Retrosternal lymphotropic chemotherapy and pneumoperitoneum in the treatment of drug-resistant destructive pulmonary tuberculosis].
    Kibrik BS; Zakharov AV; Lobanovskiĭ VM
    Probl Tuberk Bolezn Legk; 2009; (5):21-6. PubMed ID: 19565808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Susceptibility tests to second line drugs and re-treatment of tuberculosis revisiting early experiences.
    de Kantor IN; Barrera L
    Medicina (B Aires); 2007; 67(3):231-7. PubMed ID: 17628909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Tuberculosis].
    Bonnaud F; Zigani A
    Rev Prat; 2002 Oct; 52(16):1809-20. PubMed ID: 12564174
    [No Abstract]   [Full Text] [Related]  

  • 13. [Plasmapheresis in the complex treatment of patients with acutely progressive pulmonary tuberculosis].
    Makieva VG; Polosukhin SM; Dryga OP; Mishin VIu
    Probl Tuberk; 2002; (12):26-9. PubMed ID: 12611331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protease inhibitors and rifabutin: isn't the jury still out?
    Jenny-Avital ER
    Clin Infect Dis; 2001 Jan; 32(2):322-3. PubMed ID: 11170931
    [No Abstract]   [Full Text] [Related]  

  • 15. [Significance of mycobacterial drug resistance in pulmonary tuberculosis surgery].
    Repin IuM; Avetisian AO; El'kin AV; Otten TF; Riasnianskaia TE; Trofimov MA
    Probl Tuberk; 2001; (9):6-10. PubMed ID: 11858098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Impact of drug resistance of the causative agent on the outcomes of treatment for pulmonary tuberculosis in the Arkhangelsk Region].
    Tungusova OS; Nizovtseva NI; Toichkina TV; Mar'iandyshev AO; Kaugan DA; Sandven P; Bjune G
    Probl Tuberk Bolezn Legk; 2005; (9):38-43; discussion 43. PubMed ID: 16279517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Drug therapy of tuberculosis: history and present-day status].
    Khomenko AG
    Probl Tuberk; 1996; (3):2-6. PubMed ID: 8754862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effectiveness of the treatment of patients with fibrous-cavernous pulmonary tuberculosis].
    Sadykov AS
    Probl Tuberk; 1991; (8):36-8. PubMed ID: 1758855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Results of polyresistant tuberculosis treatment: data of the Santarishkes Republican tuberculous hospital].
    Mishkinis K; Kaminskaite A; Purvanetskene B
    Probl Tuberk; 1999; (1):30-1. PubMed ID: 10199180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Bactericidal therapy in patients with tuberculosis].
    Krasnov VA; Ursov IG
    Probl Tuberk Bolezn Legk; 2004; (3):21-6. PubMed ID: 15338895
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.